The Interventional Glaucoma Podcast

En este episodio del podcast sobre glaucoma intervencionista, los prestigiosos cirujanos españoles el Dr. José Belda, la Dra. María Isabel Canut y la Dra. Marta Ibarz se reúnen para comentar las razones que justifican la combinación rutinaria de la MIGS con la cirugía de cataratas y los beneficios que ofrece a los pacientes.

Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to [email protected].

In this episode of the Interventional Glaucoma podcast, Professor Gus Gazzard welcomes Professor Christophe Baudouin, Mr Gok Ratnarajan and Dr Ana Miguel to discuss the impact of glaucoma treatments on patients' quality of life, emphasising the benefits of minimally invasive glaucoma surgeries (MIGS) in reducing reliance on eye drops and improving overall patient well-being.

Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to [email protected].

In this episode of the Interventional Glaucoma podcast, Dr. Cathy McCabe, Dr. Mark Gallardo and Mr. Dan Lindfield delve into the post-operative care and expectations following the Elios procedure, highlighting the similarities to routine cataract surgery and long-term outcomes in IOP and medication reduction.

Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to [email protected].

In this episode of the Interventional Glaucoma podcast, Dr. Cathy McCabe hosts a discussion with Dr. Mark Gallardo and Mr. Dan Lindfield about intra-operative pearls for the Elios procedure. They delve into the nuances of patient positioning, visualization techniques and probe handling, offering practical insights and tips for surgeons considering adopting this innovative technology.  

Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to [email protected].

In this episode of the Interventional Glaucoma podcast, host Dr. Cathy McCabe is joined by Dr. Mark Gallardo and Mr. Dan Lindfield to explore Elios, a minimally invasive and precise solution for patients with cataracts and glaucoma. The conversation delves into patient selection criteria, effective communication strategies, and the need for a shift towards holistic patient-centered care.

Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to [email protected].

If the basic concept that impairment in aqueous humor outflow results in elevation of the IOP is a central tenet of glaucoma pathology and treatment; what three facts should all ophthalmologists know about aqueous humor dynamics?  Dr. Ike Ahmed and Professor Gus Gazzard sit down with Professor Carl Sheridan to answer this question. They highlight the clinical implications of understanding these dynamics while emphasizing the importance of early intervention and tissue preservation.

Dr. Ike Ahmed and Professor Gus Gazzard are joined by Professor Carl Sheridan to discuss the complexities of the trabecular meshwork and its significance in glaucoma management. They deconstruct some common myths and misconceptions surrounding the structure, and explore the importance of early intervention and precision treatments in obtaining maximum preservation.

Professor Gus Gazzard is joined by Ahmad Elsahn to delve into the use of excimer laser technology and its impact in shifting mindsets towards more interventional strategies for glaucoma patients. They provide insights into the distinct characteristics of the excimer laser, and discuss the safety and efficacy of the treatment.

Dr. Ike Ahmed and Professor Gus Gazzard kick off the Interventional Glaucoma podcast series with an unscripted discussion about the evolving mindset of interventional glaucoma.  They explore the motivations behind this shift, including the need to address the limitations of current treatments, and highlight cataract surgery as an opportune entry point to intervene with simultaneous glaucoma treatment.